No Data
No Data
CereVasc Announces Appointments of New Directors
Medical Device Leaders Shlomi Nachman and Timothy Scannell to join Board of DirectorsBOSTON, July 16, 2024 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel
Stryker Is Maintained at Buy by BTIG
Stryker Is Maintained at Buy by
Express News | Stryker Corporation : Morgan Stanley Raises Target Price to $350.00 From $345.00
Morgan Stanley Maintains Stryker Corp(SYK.US) With Hold Rating, Raises Target Price to $350
Morgan Stanley analyst Drew Ranieri maintains $Stryker Corp(SYK.US)$ with a hold rating, and adjusts the target price from $345 to $350.According to TipRanks data, the analyst has a success rate of 39
BTIG Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $372
BTIG analyst Ryan Zimmerman maintains $Stryker Corp(SYK.US)$ with a buy rating, and adjusts the target price from $369 to $372.According to TipRanks data, the analyst has a success rate of 46.6% and
Express News | Stryker Completes Acquisition of Artelon, Inc.
No Data